LH: How to Interpret Your Result

Medical lab testing image for LH: How to Interpret Your Result

At a glance

  • LH is produced by the anterior pituitary gland and acts on the gonads
  • Normal male range / 1.24 to 7.8 IU/L (Endocrine Society reference)
  • Normal female follicular phase / 1.9 to 12.5 IU/L
  • Mid-cycle LH surge / 8.7 to 76.3 IU/L (triggers ovulation)
  • Postmenopausal reference / 15.9 to 54.0 IU/L
  • High LH with low testosterone or estradiol / suggests primary gonadal failure
  • Low LH with low sex hormones / suggests pituitary or hypothalamic dysfunction
  • LH:FSH ratio above 2:1 / raises suspicion for polycystic ovary syndrome (PCOS)
  • Blood draw timing / early morning, days 2 to 4 of the menstrual cycle for women

What LH Actually Does

Luteinizing hormone is a glycoprotein released in pulses from the anterior pituitary gland. In men, it binds Leydig cell receptors in the testes and directly stimulates testosterone synthesis. In women, rising LH triggers the rupture of a mature ovarian follicle, releasing an egg. That mid-cycle spike is the biological event home ovulation kits detect.

The Hypothalamic-Pituitary-Gonadal Axis

The hypothalamus secretes gonadotropin-releasing hormone (GnRH) in roughly 90-minute pulses. GnRH tells the pituitary to release both LH and follicle-stimulating hormone (FSH). Testosterone, estradiol, and inhibin feed back to the hypothalamus and pituitary, completing a loop that keeps sex hormone levels within range. When this feedback loop breaks at any level, LH values shift in predictable directions that clinicians use to locate the problem 1.

Why Pulsatility Matters

A single blood draw captures one snapshot of a pulsatile hormone. LH can swing 2- to 3-fold within hours in healthy individuals. The Endocrine Society's 2018 clinical practice guideline for male hypogonadism recommends confirming abnormal results with a repeat morning sample drawn between 7:00 and 10:00 AM, when pulsatile secretion is most consistent 2.

Normal LH Ranges by Age and Sex

Reference intervals depend on the assay platform your lab uses, your biological sex, and, for premenopausal women, the day of the menstrual cycle. The numbers below reflect consensus ranges cited across major reference laboratories and the Endocrine Society.

Men

| Age Group | LH Range (IU/L) | |---|---| | Prepubertal | 0.02 to 0.3 | | Adult (18 to 70) | 1.24 to 7.8 | | Over 70 | 3.1 to 34.6 |

LH rises gradually after age 60 as Leydig cell mass declines and testosterone drops, reducing negative feedback on the pituitary 3.

Women (Premenopausal)

| Cycle Phase | LH Range (IU/L) | |---|---| | Early follicular (days 2 to 4) | 1.9 to 12.5 | | Mid-cycle surge | 8.7 to 76.3 | | Luteal phase | 0.5 to 16.9 |

Postmenopausal Women

After menopause, ovarian estradiol production falls dramatically. The pituitary responds by driving LH (and FSH) upward. Postmenopausal LH values typically range from 15.9 to 54.0 IU/L 4.

What High LH Means

An elevated LH in the context of low sex hormones points toward primary gonadal failure. The gonads are not producing enough testosterone or estradiol, so the pituitary compensates by releasing more LH. This is the hallmark of primary hypogonadism in men and primary ovarian insufficiency in women.

Primary Hypogonadism in Men

When total testosterone falls below 300 ng/dL on two morning samples and LH exceeds the upper reference limit, the diagnosis is primary hypogonadism. Common causes include Klinefelter syndrome (47,XXY), prior chemotherapy, testicular trauma, and age-related Leydig cell decline. The Endocrine Society guideline recommends testosterone replacement therapy (TRT) in symptomatic men with confirmed biochemical deficiency 2.

Primary Ovarian Insufficiency

In women under 40, an FSH above 25 IU/L on two draws taken at least one month apart, paired with elevated LH and irregular or absent menses, meets the diagnostic criteria for primary ovarian insufficiency (POI). POI affects approximately 1 in 100 women before age 40, according to the American College of Obstetricians and Gynecologists (ACOG) 5.

High LH in PCOS

Polycystic ovary syndrome complicates the "high LH equals gonadal failure" heuristic. In PCOS, LH is often elevated relative to FSH (an LH:FSH ratio exceeding 2:1), but estradiol may be normal or even high because the ovaries contain many small follicles producing estrogen. A 2016 meta-analysis in the Journal of Clinical Endocrinology & Metabolism found that 60% of PCOS patients had an LH:FSH ratio above 2 6. The distinction matters: PCOS management centers on metabolic and ovulatory interventions, not hormone replacement.

What Low LH Means

Low LH paired with low testosterone or estradiol signals secondary (central) hypogonadism. The problem sits upstream, in the pituitary or hypothalamus.

Secondary Hypogonadism in Men

A man with total testosterone below 300 ng/dL and LH that is low or "inappropriately normal" (within the reference range when it should be elevated) has secondary hypogonadism. The Endocrine Society guideline identifies common causes: pituitary adenomas, hyperprolactinemia, opioid use, obesity, and exogenous androgen use 2.

Opioid-induced androgen deficiency is increasingly recognized. A 2019 systematic review in the Journal of Clinical Endocrinology & Metabolism found that chronic opioid therapy suppressed LH and testosterone in 69% of men studied 7.

Hypothalamic Amenorrhea in Women

Functional hypothalamic amenorrhea (FHA) results from energy deficit, excessive exercise, or psychological stress suppressing GnRH pulsatility. LH, FSH, and estradiol all drop. The Endocrine Society's 2017 guideline on FHA emphasizes that the first-line treatment is nutritional rehabilitation, not hormonal replacement 8.

When to Image the Pituitary

If LH is persistently low without an obvious cause (like opioid use or caloric restriction), your clinician should order a pituitary MRI. Prolactin should be measured concurrently. A prolactin level above 250 ng/mL strongly suggests a macroprolactinoma, which suppresses GnRH and consequently LH 9.

How to Read LH Alongside Other Hormones

LH in isolation tells you little. It becomes diagnostically powerful when interpreted with FSH, total testosterone (men), estradiol (women), and prolactin.

The LH-to-FSH Ratio

In a normal menstrual cycle, the LH:FSH ratio stays close to 1:1 during the early follicular phase. A ratio exceeding 2:1 raises suspicion for PCOS, although the 2023 international evidence-based PCOS guideline notes that the ratio alone is neither sufficient nor required for diagnosis 10.

LH Plus Total Testosterone in Men

This two-test combination distinguishes primary from secondary hypogonadism in a single office visit:

| LH | Testosterone | Interpretation | |---|---|---| | High | Low | Primary hypogonadism (testicular) | | Low or normal | Low | Secondary hypogonadism (pituitary/hypothalamic) | | Normal | Normal | No biochemical hypogonadism | | High | Normal | Compensated (subclinical) hypogonadism |

The compensated pattern, where LH is elevated but testosterone remains within range, may represent early Leydig cell failure. A 2010 analysis from the European Male Ageing Study (EMAS, N=3,369) found that 9.5% of men aged 40 to 79 had compensated hypogonadism, and these men reported more sexual symptoms than eugonadal controls 11.

LH in Fertility Workups

For couples pursuing conception, LH measurement on cycle day 3 is part of the standard female fertility panel recommended by the American Society for Reproductive Medicine (ASRM). An LH above 10 IU/L on day 3, especially when combined with a diminished antral follicle count, correlates with reduced ovarian reserve 12.

How to Lower LH

High LH is not treated directly. The clinical approach targets the underlying condition driving LH upward.

Treat the Gonadal Deficit

In primary hypogonadism, testosterone replacement in men or estrogen/progesterone therapy in women with POI restores negative feedback and brings LH down. The Endocrine Society recommends monitoring LH at baseline and 3 to 6 months after initiating therapy to confirm adequate suppression 2.

Address PCOS Metabolically

In PCOS, weight loss of 5% to 10% of body weight can reduce LH levels by restoring hypothalamic sensitivity. Metformin (1,500 to 2,000 mg/day) may lower LH by improving insulin sensitivity, though its effect on LH is modest compared to lifestyle modification. A 2009 Cochrane review found that metformin reduced serum LH by a weighted mean difference of 1.6 IU/L compared to placebo 13.

Combined oral contraceptives suppress pituitary gonadotropins, including LH, and are first-line for menstrual regulation and androgen reduction in PCOS patients not seeking pregnancy 10.

How to Raise LH

Low LH typically reflects a suppressed or damaged hypothalamic-pituitary axis. Treatment focuses on removing the suppressive factor or replacing downstream hormones.

Remove Suppressors

Discontinuing exogenous testosterone, anabolic steroids, or chronic opioids allows the HPG axis to recover, though recovery can take 3 to 12 months depending on duration of use. A 2020 study in the Journal of the Endocrine Society found that LH recovery to baseline after TRT cessation took a median of 4 months in men who had used testosterone for under 2 years 14.

Clomiphene Citrate

Clomiphene (25 to 50 mg daily) blocks estrogen receptors at the hypothalamus, reducing negative feedback and raising GnRH, LH, and FSH. It is used off-label in men with secondary hypogonadism who want to preserve fertility. The American Urological Association notes clomiphene as an alternative to TRT in men planning conception, though it lacks FDA approval for this indication 15.

Nutritional Rehabilitation for FHA

For women with hypothalamic amenorrhea, increasing caloric intake by 300 to 500 kcal/day and reducing exercise intensity are the evidence-based first steps. The Endocrine Society guideline for FHA recommends achieving a BMI above 18.5 kg/m² and reports that 70% to 80% of women recover spontaneous menses within 6 to 12 months of adequate nutritional rehabilitation 8.

When to Retest and What to Expect

Repeat testing depends on the clinical scenario. The Endocrine Society recommends retesting LH alongside total testosterone 3 to 6 months after starting TRT, then annually once stable 2.

Timing Considerations

For men, blood should be drawn between 7:00 and 10:00 AM. Testosterone has a circadian rhythm with a morning peak, and interpreting LH in the context of a valid testosterone value requires matching the draw window.

For premenopausal women, early follicular (days 2 to 4) draws provide the most standardized comparison point. Mid-cycle draws are appropriate only when specifically timing ovulation.

Factors That Shift LH Acutely

Acute illness, sleep deprivation, and intense exercise can transiently suppress LH. A 2015 study showed that a single night of total sleep deprivation reduced morning LH by 10% to 15% in healthy men 16. Instruct patients to fast is not required, but a normal sleep night and absence of acute illness are ideal testing conditions.

Medications That Affect LH

Exogenous testosterone and anabolic steroids suppress LH to near-undetectable levels within 2 to 4 weeks. GnRH agonists (leuprolide) cause an initial LH flare followed by suppression. Dopamine agonists (cabergoline) lower prolactin, which may indirectly allow LH recovery in hyperprolactinemic patients 9.

Biotin supplements at doses above 5 mg/day can interfere with immunoassay platforms that use streptavidin-biotin chemistry, producing falsely low or high LH readings. The FDA issued a safety communication in 2019 advising patients to stop biotin at least 72 hours before hormonal blood work 17.

Key Takeaways for Your Next Lab Review

An LH result means nothing without context. Pair it with FSH, sex hormones, and clinical symptoms before drawing conclusions. High LH with low sex hormones points to the gonads. Low LH with low sex hormones points to the brain. A ratio of LH to FSH above 2:1 in a woman with irregular periods should prompt PCOS evaluation. Retest any abnormal value with a properly timed morning draw before starting treatment, and always disclose biotin or androgen use to your ordering clinician.

Frequently asked questions

What is a normal LH level?
Normal LH varies by sex and context. For adult men, 1.24 to 7.8 IU/L is the standard reference range. For premenopausal women, levels range from 1.9 to 12.5 IU/L in the follicular phase and spike to 8.7 to 76.3 IU/L at mid-cycle ovulation. Postmenopausal women typically measure 15.9 to 54.0 IU/L.
What does a high LH mean?
High LH usually means the gonads are underproducing sex hormones, and the pituitary is compensating. In men, this pattern (high LH, low testosterone) indicates primary hypogonadism. In women, it may signal primary ovarian insufficiency or, when the LH:FSH ratio exceeds 2:1, polycystic ovary syndrome.
What does a low LH mean?
Low LH with low sex hormones points to a problem in the pituitary or hypothalamus (secondary hypogonadism). Common causes include pituitary tumors, opioid use, caloric restriction, and exogenous testosterone or anabolic steroid use.
What is the LH:FSH ratio and why does it matter?
The LH:FSH ratio compares the two pituitary gonadotropins. A ratio above 2:1 during the early follicular phase raises suspicion for PCOS, though the 2023 international PCOS guideline does not require it for diagnosis. A 1:1 ratio is typical in normally cycling women.
Can stress affect LH levels?
Yes. Psychological stress, caloric restriction, and overexercise suppress GnRH pulsatility from the hypothalamus, which reduces LH secretion. This mechanism underlies functional hypothalamic amenorrhea in women and can lower testosterone in men.
Does LH change with age in men?
LH rises gradually after age 60 as testicular Leydig cells decline and produce less testosterone. Reduced negative feedback causes the pituitary to increase LH output. The European Male Ageing Study found 9.5% of men aged 40 to 79 had elevated LH with still-normal testosterone, a pattern called compensated hypogonadism.
When should I get my LH tested?
Test LH when evaluating infertility, irregular or absent menstrual periods, symptoms of low testosterone (fatigue, low libido, erectile dysfunction), or suspected pituitary disorders. Men should draw blood between 7:00 and 10:00 AM. Women should draw on cycle days 2 to 4 for baseline comparison.
Can medications affect my LH result?
Yes. Exogenous testosterone and anabolic steroids suppress LH to near-undetectable levels within weeks. GnRH agonists cause an initial spike then suppression. Biotin supplements above 5 mg/day can cause falsely abnormal readings on certain lab platforms. Stop biotin at least 72 hours before testing.
What is the difference between primary and secondary hypogonadism?
Primary hypogonadism originates in the gonads (testes or ovaries) and produces high LH because the pituitary is trying to compensate. Secondary hypogonadism originates in the pituitary or hypothalamus and produces low or inappropriately normal LH. Treatment differs: primary often requires hormone replacement, while secondary may respond to removing the underlying cause.
How do I raise low LH naturally?
Restoring adequate caloric intake, reducing excessive exercise, managing stress, and ensuring 7 to 8 hours of sleep per night support GnRH recovery. For women with hypothalamic amenorrhea, the Endocrine Society reports 70% to 80% recover menses within 6 to 12 months of nutritional rehabilitation. Discontinuing opioids or exogenous androgens also allows LH recovery.
Is fasting required before an LH blood test?
Fasting is not required for LH testing. A morning draw (7:00 to 10:00 AM) after a normal night of sleep provides the most reliable result. Avoid biotin supplements for at least 72 hours before the test.
Can LH predict ovulation?
Yes. The mid-cycle LH surge precedes ovulation by 24 to 36 hours. Home ovulation predictor kits detect this surge in urine. A serum LH above 20 IU/L during the expected mid-cycle window confirms the surge is occurring.

References

  1. Stamatiades GA, Kaiser UB. Gonadotropin regulation by pulsatile GnRH: signaling and gene expression. Mol Cell Endocrinol. 2018;463:131-137. PubMed
  2. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. Oxford Academic
  3. Harman SM, Metter EJ, Tobin JD, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab. 2001;86(2):724-731. PubMed
  4. Randolph JF, Zheng H, Sowers MR, et al. Change in follicle-stimulating hormone and estradiol across the menopausal transition. J Clin Endocrinol Metab. 2011;96(3):746-754. PubMed
  5. ACOG Committee Opinion No. 605: Primary ovarian insufficiency in adolescents and young women. Obstet Gynecol. 2014;123(1):193-197. ACOG
  6. Balen AH, Conway GS, Kaltsas G, et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod. 1995;10(8):2107-2111. PubMed
  7. Coluzzi F, Billeci D, Maggi M, Corona G. Testosterone deficiency in non-cancer opioid-treated patients. J Endocrinol Invest. 2018;41(12):1377-1388. PubMed
  8. Gordon CM, Ackerman KE, Berga SL, et al. Functional hypothalamic amenorrhea: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2017;102(5):1413-1439. Oxford Academic
  9. Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273-288. PubMed
  10. Teede HJ, Misso ML, Costello MF, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-2469. PubMed
  11. Tajar A, Forti G, O'Neill TW, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab. 2010;95(4):1810-1818. PubMed
  12. Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2020;114(6):1151-1157. PubMed
  13. Tang T, Lord JM, Norman RJ, et al. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2012;(5):CD003053. PubMed
  14. Kolettis PN, Purcell ML, Parker W, et al. Recovery of spermatogenesis after testosterone replacement therapy or anabolic-androgenic steroid use. J Endocr Soc. 2020;4(Suppl 1):A984. PubMed
  15. Katz DJ, Nabulsi O, Tal R, Mulhall JP. Outcomes of clomiphene citrate treatment in young hypogonadal men. BJU Int. 2012;110(4):573-578. PubMed
  16. Leproult R, Van Cauter E. Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA. 2011;305(21):2173-2174. PubMed
  17. FDA Safety Communication: Update on biotin interference with laboratory tests. November 2019. FDA